NARDONE, Gerardo
 Distribuzione geografica
Continente #
NA - Nord America 17.317
AS - Asia 14.427
EU - Europa 9.186
SA - Sud America 2.011
Continente sconosciuto - Info sul continente non disponibili 495
AF - Africa 342
OC - Oceania 16
Totale 43.794
Nazione #
US - Stati Uniti d'America 16.578
SG - Singapore 6.819
RU - Federazione Russa 4.048
CN - Cina 2.608
VN - Vietnam 2.222
BR - Brasile 1.566
IT - Italia 1.477
HK - Hong Kong 1.187
FR - Francia 557
DE - Germania 553
UA - Ucraina 519
FI - Finlandia 473
IE - Irlanda 403
CA - Canada 394
NL - Olanda 297
GB - Regno Unito 290
IN - India 285
JP - Giappone 281
BD - Bangladesh 219
SE - Svezia 215
AR - Argentina 164
MX - Messico 164
KR - Corea 104
IQ - Iraq 92
EC - Ecuador 85
PK - Pakistan 85
ZA - Sudafrica 83
PL - Polonia 78
ES - Italia 76
PH - Filippine 66
ID - Indonesia 61
TH - Thailandia 60
TR - Turchia 60
CI - Costa d'Avorio 58
CO - Colombia 53
TW - Taiwan 42
AT - Austria 41
JM - Giamaica 36
VE - Venezuela 30
MA - Marocco 29
CL - Cile 27
PE - Perù 27
JO - Giordania 26
BE - Belgio 25
KE - Kenya 25
CR - Costa Rica 24
IL - Israele 24
PY - Paraguay 23
HN - Honduras 22
UZ - Uzbekistan 22
NP - Nepal 21
DZ - Algeria 20
EG - Egitto 20
LT - Lituania 18
MY - Malesia 18
BO - Bolivia 17
TT - Trinidad e Tobago 16
UY - Uruguay 16
AE - Emirati Arabi Uniti 15
IR - Iran 13
KZ - Kazakistan 13
TN - Tunisia 13
SA - Arabia Saudita 12
DO - Repubblica Dominicana 11
EU - Europa 11
LB - Libano 11
CZ - Repubblica Ceca 10
ET - Etiopia 10
RO - Romania 10
RS - Serbia 10
GT - Guatemala 9
LV - Lettonia 9
AU - Australia 8
BB - Barbados 8
CH - Svizzera 8
EE - Estonia 8
SC - Seychelles 8
AO - Angola 7
HR - Croazia 7
KG - Kirghizistan 7
NG - Nigeria 7
PR - Porto Rico 7
PT - Portogallo 7
SV - El Salvador 7
AM - Armenia 6
AZ - Azerbaigian 6
CM - Camerun 6
DK - Danimarca 6
GA - Gabon 6
HU - Ungheria 6
OM - Oman 6
SY - Repubblica araba siriana 6
BG - Bulgaria 5
BY - Bielorussia 5
GE - Georgia 5
KH - Cambogia 5
NI - Nicaragua 5
PA - Panama 5
PS - Palestinian Territory 5
AL - Albania 4
Totale 43.182
Città #
Singapore 3.071
San Jose 2.126
Ashburn 1.425
Hong Kong 1.145
Moscow 978
Chandler 845
Council Bluffs 693
Ho Chi Minh City 613
Santa Clara 586
Beijing 538
Jacksonville 521
Hanoi 519
The Dalles 444
Los Angeles 437
Millbury 430
Princeton 399
Lauterbourg 381
Hefei 372
Naples 325
Woodbridge 284
Boston 279
New York 279
Nanjing 264
Tokyo 264
Amsterdam 238
Dallas 221
Buffalo 204
Houston 181
São Paulo 158
Wilmington 156
Munich 153
Phoenix 146
Ann Arbor 139
Napoli 131
Ottawa 121
Redondo Beach 103
Da Nang 98
Atlanta 97
Rome 97
Nanchang 96
San Francisco 93
Denver 91
Chicago 89
Montreal 86
Orem 82
Haiphong 78
Milan 75
Shenyang 75
Brooklyn 71
Norwalk 70
Seoul 67
Hebei 66
Mexico City 65
Seattle 64
Des Moines 63
Toronto 62
Frankfurt am Main 59
Cagliari 56
Warsaw 56
Turku 53
Tianjin 49
Rio de Janeiro 48
Jiaxing 46
Changsha 45
Johannesburg 44
Kronberg 44
Chennai 43
Washington 43
London 42
Nuremberg 42
Falls Church 41
Helsinki 41
Boardman 40
Kochi 39
Belo Horizonte 36
Biên Hòa 34
Baghdad 33
Hải Dương 30
Lawrence 29
Orange 28
Stockholm 28
Guayaquil 27
Curitiba 26
Manchester 26
Poplar 26
Brasília 25
Palermo 25
Dong Ket 24
Mumbai 24
Quito 24
Amman 23
Ankara 23
Hangzhou 23
Nairobi 23
Ninh Bình 23
North Bergen 23
Porto Alegre 23
Erbil 22
Lima 22
Kingston 21
Totale 22.256
Nome #
Effects of carbonated water on functional dyspepsia and constipation. 1.141
Sweetened carbonated drinks do not alter upper digestive tract physiology in healthy subjects 948
Vascular endothelial growth factor and cyclooxygenase-2 are overexpressed in ileal pouch-anal anastomosis. 279
Effects of long-term PPI treatment on producing bowel symptoms and SIBO 277
1st Rome H2-Breath Testing Consensus Conference Working Group. Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. 247
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 218
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 194
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 191
Reproducibility of shear wave elastography (SWE) in patients with chronic liver disease 188
Alcoholic disease: Liver and beyond 181
Gastric Normal Adjacent Mucosa Versus Healthy and Cancer Tissues: Distinctive Transcriptomic Profiles and Biological Features 177
Vitamin B12 supplementation improves rates ofsustained viral response in patients chronicallyinfected with hepatitis C virus 174
Adherence to Barcelona Clinic Liver Cancer guidelines in field practice: Results of Progetto Epatocarcinoma Campania 174
Quality of bowel cleansing in hospetalized patients undergoing colonoscopy: a multicenter prospective regional study 170
Sexual dysfunctions in inflammatory bowel disease: role of Mediterranean diet and quality of life 167
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 166
Quantitative analysis of aldolase A mRNA in liver discriminates between hepatocellular carcinoma and cirrhosis. 166
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination 165
Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disorders 164
Risk factors for cancer development in helicobacter pylori gastritis. 163
Nutritional state and energy balance in cirrhotic patients with or without hypermetabolism Multicentre prospective study by the 'Nutritional Problems in Gastroenterology' Section of the Italian Society of Gastroenterology 162
Matrix metalloproteinase-9expression and polyphenols extracts effect on MKN-28 cells 162
Impact of proton pump inhibitors on cytochrome P450 activity assessed by 13C-aminopyrine breath test in patients with cirrhosis 161
Bowel movement alterations predict the severity of diverticular disease and the risk of acute diverticulitis: a prospective, international study 157
Incidence and distribution of coeliac disease in Campania (Italy): 2011-2013 154
Large Brunner's gland adenoma: Case report and literature review. 153
Esofago di Barrett 153
The dica endoscopic classification for diverticular disease of the colon shows a significant interobserver agreement among community endoscopists: An international study 153
Ultrasonographic diagnosis of ileo-ileal intussusception secondary to Vanek's tumor 150
Overview of prognostic systems for hepatocellular carcinoma and ITA.LI.CA external validation of MESH and CNLC classifications 150
MANUALE DI GASTROENTEROLOGIA DIETISTI 150
Lactobacillus paracasei F19 versus placebo for the prevention of proton pump inhibitor-induced bowel symptoms: A randomized clinical trial 150
The metabolic role of gut microbiota in the development of nonalcoholic fatty liver disease and cardiovascular disease 150
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 149
Long-lasting intestinal bleeding in an old patient with multiple mucosal vascular abnormalities and Glanzmann's thrombasthenia: 3-year pharmacological management. 149
A RAT MODEL OF OXIDATIVE AND METABOLIC HEPATIC INJURY: THE POTENTIAL PROTECTIVE ROLE OF LACTOBACILLUS PARACASEI F19 148
Pattern of macrovascular invasion in hepatocellular carcinoma 148
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 147
Autoimmune liver diseases and SARS-CoV-2 147
Intestinal amyloidosis: two cases with different patternsof clinical and imaging presentation 147
The “dica” endoscopic classification for diverticular disease of the colon shows a significant interobserver agreement among community endoscopists 146
Surveillance for hepatocellular carcinoma with a 3-months interval in “extremely high-risk” patients does not further improve survival 145
Gut Microbes and Hepatic Encephalopathy: From the Old Concepts to New Perspectives 145
Non-bismuth and bismuth quadruple therapies based on previous clarithromycin exposure are as effective and safe in an area of high clarithromycin resistance: A real-life study 145
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors 144
The professional background of a referring physician predicts the diagnostic yield of small bowel capsule endoscopy in suspected small bowel bleeding 142
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 142
Gastro-duodenal lesions and Helicobacter pylori infection in dyspeptic patients with and without chronic renal failure 142
Blinded oral challenges with lactose and placebo accurately diagnose lactose intolerance: a real‐life study 141
Cd133 and Cd44 Cell Surface Markers Do Not Identify Cancer Stem Cells In Primary Human Gastric Tumours 141
Gastrokine 1 expression in patients with and without Helicobacter pylori infection. 140
Relationship between cyclooxygenese-2 and p-glycoprotein expression in H. pylori- positive gastritis non responders to eradication therapy 140
Invasive pulmonary aspergillosis and pulmonary tuberculosis in a patient treated with infliximab for Crohn's disease 140
Predicting de-novo portal vein thrombosis after HCV eradication: A long-term competing risk analysis in the ongoing PITER cohort 139
Probiotics in Gastrointestinal Diseases: All that Glitters Is Not Gold 138
Is screening for and surveillance of atrophic gastritis advisable? 137
Transarterial Chemoembolization for Hepatocellular Carcinoma in Clinical Practice: Temporal Trends and Survival Outcomes of an Iterative Treatment 136
Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: An ex-vivo organ culture model of post-infectious irritable bowel syndrome 136
Performance characteristics of an enzime-linked immunosorbent assay for determining salivary immunoglobulin G response to Helicobacter Pylori 135
Effects of carbonated water on functional dyspepsia and constipation. 135
Apoptosis and cytologic differentiation in hepatocellular carcinoma on fine needle aspiration samples. 135
CD133 and CD44 Cell surface markers do not identify cancer stem cells in primary human gastric tumors 135
Plasma dosage of ghrelin, IGF-1, GLP- 1 and leptin related to gastric emptying and esophageal pH-impedance in children with obesity 135
Development of a risk score to predict portal vein tumor thrombosis in patients with hepatocellular carcinoma 134
MDR1-P-glycoprotein behaves as an oncofetal protein that promotes cell survival in gastric cancer cells 134
Changes of protein expression in Helicobacter pylori-infected human gastric mucosa 133
Age-specific prevalence of Helicobacter pylori infection and morphological findings of gastric mucosa. A retrospective study in a symptomatic pediatric population of southern Italy. 133
Gastric Emptying Impacts the Timing of Meal Glucose Peak in Subjects with Uncomplicated Type 1 Diabetes 133
Gastric atrophy and intestinal metaplasia changes 8 years after Helicobacter pylori eradication. A blind, randomised study. 132
Coeliac diseas and unfavourable outcome of pregnancy. 132
Gut microbiota and irritable bowel syndrome 132
Prognostic performance of the 'DICA' endoscopic classification and the 'CODA' score in predicting clinical outcomes of diverticular disease: an international, multicentre, prospective cohort study 131
A nomogram-based prognostic model for advanced hepatocellular carcinoma patients treated with sorafenib: A multicenter study 129
Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular Carcinoma 128
Effect of Helicobacter Pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis. 128
Altered trafficking of EGF in endocytic proliferation and innate immunity markers in MARSH 0 (M0) biopsies of celiac patients. 127
Gut--liver axis: the impact of gut microbiota on non alcoholic fatty liver disease 127
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database 126
Cell proliferation and genomic instability in chronic gastritis, with and without Helicobacter pylori infection, and in gastric cancer. 126
MDR1-P-glycoprotein behaves as an oncofetal protein that promotes cell survival in gastric cancer cells 126
Characteristics and outcome of anti-hepatitis D virus positive patients with hepatocellular carcinoma 125
Helicobacter pylori and epigenetic mechanisms underlying gastric carcinogenesis. 125
Effect of Helicobacter Pylori infection on gastric cell proliferation and genomic instability in a paediatric population of southern Italy. 125
I livelli tessutali di grelina non correlano con il tempo di svuotamento gastrico 125
Increased prevalence of rare sucrase-isomaltase (SI) pathogenic variants in irritable bowel syndrome patients 125
Female-Specific Association Between Variants on Chromosome 9 and Self-Reported Diagnosis of Irritable Bowel Syndrome 124
MDR1-P-glycoprotein behaves as an oncofetal protein that promotes cell survival in gastric cancer cells 124
Diagnosis of chronic atrophic gastritis by morphometric image analysis. A new method to overcome the confounding effect of the inflammatory infiltrate. 123
13C-AMINOPYRINE BREATH TEST PREDICTS THE CLINICAL OUTCOME IN PATIENTS WITH C VIRUS-RELATED CHRONIC HEPATITIS 123
POLYPHENOL EXTRACTS PROTECT GASTRIC CANCER CELLFROM OXIDATIVE STRESS-INDUCED DAMAGE 123
Diagnostic accuracy of the serum profile of gastric mucosa in relation to histological and morphometric diagnosis of atrophy 122
A mannose-binding lectin-defective haplotype is a risk factor for gastric cancer. 122
Gastric emptying time and prevalence of small intestinal bacterial overgrowth in newly diagnosed celiac disease patients 122
Green tea polyphenols affect invasiveness of human gastric MKN-28 cells by inhibition of LPS or TNF-α induced Matrix Metalloproteinase-9/2 121
Up-regulation of heparin binding epidermal growth factor-like growth factor and amphiregulin expression in Helicobacter pylori-infected human gastric mucosa. 120
Increased severity of dyspeptic symptoms related to mental stress is associated with sympathetic hyperactivity and enhanced endocrine response in patients with postprandial distress syndrome 120
Predictors of non-transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection 119
Expression of COX-2, mPGE-synthase1, MDR-1 (P-gp), and Bcl-xL: a molecular pathway of H pylori-related gastric carcinogenesis. 119
Molecular basis of gastric carcinogenesesis 118
Mdr1 P-glycoprotein expression in human gastric tissue: From ontogenesis to carcinogenesis 118
Totale 16.458
Categoria #
all - tutte 144.602
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 144.602


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.942 0 0 0 0 5 56 8 72 410 108 342 941
2022/20232.115 426 138 46 171 257 240 14 191 273 234 105 20
2023/20241.534 60 223 222 114 71 138 15 183 25 33 329 121
2024/202510.006 567 788 61 123 256 436 1.112 528 1.150 934 3.119 932
2025/202618.183 2.043 1.372 1.843 1.488 3.056 699 1.887 1.371 2.306 1.122 471 525
2026/20275.451 1.123 1.085 1.245 1.926 72 0 0 0 0 0 0 0
Totale 43.794